Tag: Cutaneous

Pharma / Biotech

Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma.

Newsemia
Related Articles Open-label, phase IIa study of dabrafenib plus trametinib in East Asian patients with advanced BRAF V600-mutant cutaneous melanoma. Eur J Cancer. 2020 Jun...
Latest News

GW expands clinical trial of neoadjuvant immunotherapy for high-risk cutaneous squamous cell carcinoma

Newsemia
The Cutaneous Oncology Program at the George Washington University (GW) Cancer Center was selected as the first global site for a clinical trial for patients...
Pharma / Biotech

Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma.

Newsemia
Related Articles Phase I study of the anti-endothelin B receptor antibody-drug conjugate DEDN6526A in patients with metastatic or unresectable cutaneous, mucosal, or uveal melanoma. Invest...
Pharma / Biotech

Study of pharmacokinetics and cutaneous photosensitization of Hemoporfin in healthy volunteers.

Newsemia
Related Articles Study of pharmacokinetics and cutaneous photosensitization of Hemoporfin in healthy volunteers. Photodiagnosis Photodyn Ther. 2019 Feb 26;: Authors: Xu J, Zhao X, Wu...
Pediatrics

Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry.

Newsemia
Related Articles Severe Cutaneous Adverse Reactions in Korean Pediatric Patients: A Study From the Korea SCAR Registry. Allergy Asthma Immunol Res. 2019 Mar;11(2):241-253 Authors: Oh...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World